| Who is it? | Researcher |
| Birth Day | July 02, 1946 |
| Birth Place | Brooklyn, New York City, United States |
| Age | 76 YEARS OLD |
| Birth Sign | Leo |
| Residence | USA |
| Citizenship | United States |
| Alma mater | Stuyvesant High School Columbia University Johns Hopkins School of Medicine |
| Spouse(s) | Cornelia Bargmann |
| Awards | Richard Lounsbery Award (1989) Gairdner Foundation International Award (2003) Nobel Prize in Physiology or Medicine (2004) ForMemRS (2014) |
| Fields | Neuroscience |
| Institutions | Columbia University |
| Notable students | Linda Buck David J. Anderson Catherine Dulac David Julius Richard Scheller |
| Website | www.axellab.columbia.edu |
Richard Axel, a renowned researcher based in the United States, is estimated to have a net worth ranging from $100,000 to $1 million in 2024. With a distinguished career in the field of research, Richard Axel has made significant contributions to the scientific community. His expertise and innovative approaches have garnered him recognition and success in his endeavors. With such accomplishments, it is no surprise that Richard Axel's net worth reflects his remarkable achievements and ongoing contributions to the field of research.
In addition to the Nobel Prize, Axel has won numerous awards and honors. He was elected a Fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences in 1983. Axel was awarded the Double Helix Medal in 2007. CSHL Double Helix Medal Honoree and was elected a Foreign Member of the Royal Society (ForMemRS) in 2014. His nomination reads:
Born in New York City, New York, Axel graduated from Stuyvesant High School in 1963, received his A.B. in 1967 from Columbia University, and his M.D. in 1971 from Johns Hopkins University. He returned to Columbia later that year and became a full professor in 1978.
During the late 1970s, Axel, along with microbiologist Saul J. Silverstein and Geneticist Michael H. Wigler, discovered a technique of cotransformation via transfection, a process which allows foreign DNA to be inserted into a host cell to produce certain proteins. A family of patents, now colloquially referred to as the "Axel patents", covering this technique were filed for February 1980 and were issued in August 1983. As a fundamental process in recombinant DNA research as performed at pharmaceutical and biotech companies, this patent proved quite lucrative for Columbia University, earning it almost $100 million a year at one time, and a top spot on the list of top universities by licensing revenue. The Axel patents expired in August 2000.
In addition to the Nobel Prize, Axel has won numerous awards and honors. He was elected a Fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences in 1983. Axel was awarded the Double Helix Medal in 2007. CSHL Double Helix Medal Honoree and was elected a Foreign Member of the Royal Society (ForMemRS) in 2014. His nomination reads:
In their landmark paper published in 1991, Buck and Axel cloned olfactory receptors, showing that they belong to the family of G protein coupled receptors. By analyzing rat DNA, they estimated that there were approximately one thousand different genes for olfactory receptors in the mammalian genome. This research opened the door to the genetic and molecular analysis of the mechanisms of olfaction. In their later work, Buck and Axel have shown that each olfactory receptor neuron remarkably only expresses one kind of olfactory receptor protein and that the input from all neurons expressing the same receptor is collected by a single dedicated glomerulus of the olfactory bulb.
